Literature DB >> 31431731

Rescuing imperfect antigens for immuno-oncology.

Selena J Lorrey1,2, Luis Sanchez-Perez2,3, Peter E Fecci4,5,6.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2019        PMID： 31431731     DOI： 10.1038/s41587-019-0248-2

Source DB:  PubMed          Journal:  Nat Biotechnol        ISSN： 1087-0156            Impact factor:   54.908


× No keyword cloud information.
  2 in total

Review 1.  Translating anti-CD19 CAR T-cell therapy into clinical practice for relapsed/refractory diffuse large B-cell lymphoma.

Authors:  Victor A Chow; Mazyar Shadman; Ajay K Gopal
Journal:  Blood       Date:  2018-06-18       Impact factor: 22.113

2.  Cell surface localization and density of the tumor-associated variant of the epidermal growth factor receptor, EGFRvIII.

Authors:  C J Wikstrand; R E McLendon; A H Friedman; D D Bigner
Journal:  Cancer Res       Date:  1997-09-15       Impact factor: 12.701
  2 in total
  1 in total

Review 1.  T-Cell based therapies for overcoming neuroanatomical and immunosuppressive challenges within the glioma microenvironment.

Authors:  Darwin Kwok; Hideho Okada
Journal:  J Neurooncol       Date:  2020-03-17       Impact factor: 4.130
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.